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Recent publications by Kim et al. (Kim, K., Doi,
A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim,
J., Aryee, M.J., Ji, H., Ehrlich, L.I., et al.
(2010). Nature, in press. Published online JulyCell Stem Cel19, 2010. 10.1038/nature09342) and Polo et al.
(Polo, J.M., Liu, S., Figueroa, M.E., Kulalert,
W., Eminli, S., Tan, K.Y., Apostolou, E., Stadt-
feld, M., Li, Y., Shioda, T. et al. (2010). Nat. Bio-
technol., in press. Published online July 19,
2010. 10.1038/nbt.1667) extend on the publica-
tions previewed here. In brief, Kim et al. and
Polo et al. show that mouse iPSCs derived
from distinct differentiated cell types show
defining transcriptional and epigenetic similari-
ties with their starting cell of origin. This reten-
tion of the starting cell’s transcriptional program
in iPSCs could explain why certain genes are
differentially expressed between human iPSCs
and ESCs, as discussed here. Furthermore,
Polo et al. show that after extended passaging,
mouse iPSCs largely censor these cell-of-
origin-specific transcriptional programs, thus af-
firming Chin et al. (2009)’s findings that
extended passaging of human iPSC lines
increases their transcriptional similarity to human
ESC lines.Getting to the Heart of the Matter:
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Since MyoD was used to convert fibroblasts directly to skeletal muscle, biologists have tried to apply this
strategy to generate other cell lineages. In their recentCell paper, Ieda et al. (2010) use selected cardiac tran-
scription factors to directly reprogram fibroblasts to cardiomyocytes without passing through an intervening
pluripotent state.A landmark paper from Takahashi and
Yamanaka (2006) showed that adult
mammalian cells could be reverted to
a pluripotent state with just four transcrip-
tion factors. Before that time, pluripotent
cell reprogramming was thought to re-
quire either somatic cell nuclear transfer
into an unfertilized egg cell or fusion of
somatic cells with pluripotent embryonic
stem cells (ESCs) (Hochedlinger and
Jaenisch, 2006). Direct reprogramming
of terminally differentiated cells, also
called lineage reprogramming, had been
limited to skeletal muscle via MyoD. This
transcription factor became recognized
as a ‘‘master regulator gene,’’ because
it was able to convert fibroblasts, chon-
drocytes, and retinal epithelium into con-
tracting muscle in culture (Choi et al.,1990). Subsequent examples included
the conversion of B lymphocytes into
macrophages by CEP/B (Xie et al., 2004)
and inner ear support cells into sensory
hair cells by Math1 (Izumikawa et al.,
2005). Yet, despite years of research,
master regulators for other lineages have
remained elusive. Now, with an approach
similar to Yamanaka’s, Srivistava and
colleagues demonstrate that fully func-
tional cardiomyocytes can be derived
from cardiac and skin fibroblasts (Ieda
et al., 2010).
Master Regulators: A Team
Approach
Yamanaka demonstrated that a selected
group of transcription factors was suffi-
cient to direct somatic cells to adoptan immature pluripotent state and that
this conversion involved the loss of
the original imprint that determined the
cells’ functional characteristics. This find-
ing helped shift the field’s approach to
lineage reprogramming. Instead of per-
forming modest searches for single mas-
ter regulator genes, hundreds of critical
developmental factors were screened
in multiple combinations with lineage
reporter cells as readouts. Yamanaka’s
protocol reduced several hundred pluri-
potency candidate genes to just four.
Why not try the same direct reprogram-
ming paradigm to generate specific differ-
entiated cell lineages?
Melton and colleagues applied this
technique successfully to identify a
small set of genes capable of convertingl 7, August 6, 2010 ª2010 Elsevier Inc. 139
Figure 1. Cardiomyocyte Formation by Direct Programming or Differentiation of Pluripotent
Stem Cells
Top: Transcription factors Gata4, Mef2c, and Tbx5 directly reprogram fibroblasts (FB) to cardiomyocytes
(CM) without intervening cardiac progenitor cell (CPC) or pluripotent stem cell stages (left). Alternatively,
fibroblasts are reprogrammed to induced pluripotent stem cells (iPSCs) by inducing factors Oct3/4, Sox2,
c-Myc, and Klf4 (1). Cardiomyocyte production requires specific induction protocols, which support differ-
entiation through sequential developmental stages from CPCs (2) to CMs (3). Pluripotent embryonic stem
cells (ESCs) offer an alternative source to yield cardiomyocytes via similar differentiation paradigms.
Bottom: Somatic cells are reprogrammed to induced pluripotent stem cells (dark gray) or to specific cell
types (direct reprogramming, light gray) with varying efficiencies.
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Previewsexocrine pancreas cells into endocrine
pancreas, the b-islet cells essential for
regulated insulin production (Zhou et al.,
2008). By using genome-wide expres-
sion analysis, the authors narrowed
down >1100 transcription factors ex-
pressed in the developing mouse pan-
creas to 30 associated with pancreatic
and endocrine progenitors, 9 of which
were known to be required for b-cell fate
specification. After an in vivo process
of elimination, a trio of factors proved
capable of converting exocrine pancreas
tissue into functional endocrine cells.
Although present only as single cells and
not in b-cell clusters, the results demon-
strated the principle that combinations of
developmentally relevant genescandirect
lineage reprogramming in vivo.
A subsequent study from Wernig and
colleagues used a similar approach to
produce neurons from both mouse
embryonic and postnatal fibroblasts (Vier-
buchen et al., 2010). A pool of 19 candi-
date developmental genes expressed
in neural tissue yielded a combination of
three transcription factors Ascl1, Brn2,140 Cell Stem Cell 7, August 6, 2010 ª2010 Eand Mytl1 that was sufficient for the
induction of functional neuronal cells.
Lineage Reprogramming
to Cardiomyocytes
In their current Cell paper, Srivastava and
colleagues endeavoured to reprogram
committed fibroblasts to cardiomyocytes
and started with a pool of 14 candidate
cardiomyocyte-inducing factors (Ieda
et al., 2010). Cardiomyocyte induction of
mouse neonatal cardiac fibroblasts was
observed 1 week after retroviral transduc-
tion in 1.7% of the cells. After fine tuning
the cocktail to combine crucial cardiac-
inducing factors and exclude inhibitory
or ineffective factors, a best set was
identified, consisting of the transcription
factors Gata4, Mef2c, and Tbx5 (Figure 1,
top). Use of this trio of factors increased
the efficiency of direct cardiomyocyte
induction to a remarkable 20%. Although
inducedcardiomyocytes (iCMs) displayed
expression of cardiac proteins within
a week, their further maturation occurred
in the weeks thereafter: sarcomeric orga-
nization and contractility increased andlsevier Inc.electrical properties ‘‘matured.’’ As
expected for true reprogramming, epi-
genetic resetting of a selected group of
genes to that of a cardiomyocyte state
was evident. Furthermore, by using induc-
ible lentiviral expression, the authors
showed that iCMs were stable for at least
1 week after the three factors were
switched off.
Because the cardiomyocytes derived
from a starting population of cardiac fibro-
blasts could in principle have originated
from rare, contaminating cardiac progen-
itor subpopulations, the procedure was
repeated with dermal fibroblasts isolated
from tail tips of adult mice. Direct re-
programming of somatic cells to cardio-
myocytes was confirmed in this manner
and in fact, conversion efficiencies were
comparable between the two targeted
fibroblast populations.
Most interestingly, in comparison
to reprogramming of somatic cells to
induced pluripotent stem cells (iPSCs),
lineage reprogramming (both for cardio-
myocytes as well as neuronal cells)
appears to be rapid and relatively much
more efficient (Figure 1, bottom). Srivas-
tava and colleagues propose that the
difference in effciencies may be explained
by the fact that the cells are directly con-
verted to cardiomyocytes without revert-
ing to precardiac developmental stages
such as mesoderm or cardiac progenitor
cells (Figure 1, top).
Where Next and Which
Applications?
Based on current and previous findings,
Gata4, Mef2c, and Tbx5 are clearly crucial
for cardiac development and can promote
cardiac differentiation. However, it is
surprising to see that Nkx2-5, another
core cardiac transcription factor, inhibited
rather than enhanced cardiomyocyte re-
programming efficiency. A recent study
by Takeuchi and Bruneau (2009) found
thatGata4andTbx5withBaf60c,asubunit
of the Swi/Snf-like BAF chromatin-remod-
elling complex, was sufficient to transdif-
ferentiate noncardiogenic mouse meso-
derm to cardiomyocytes. In this example,
Nkx2-5 was not one of a minimal set of
factors required for cardiac differentiation,
but its expression was induced by the
combination of Gata4 and Baf60c. Inter-
estingly, Takeuchi and Bruneau’s cocktail
of Gata4, Tbx5, and Baf60c was not
sufficient to reprogram fibroblasts in the
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difference between the two studies is
the differentiation status of the targeted
cells: fully differentiated fibroblasts versus
unspecified mesodermal cells. Fibroblast
conversion to cardiomyocytes can pro-
ceed without an intervening mesodermal
or progenitor stage (Ieda et al., 2010),
so it is conceivable that distinct starting
cells may respond differently to the same
factors. It would be of interest to investi-
gate whether inducible and temporal
activation of selected factors would
affect reprogramming efficiency, epige-
netic status, maturation, function, and
stability of the resulting cardiomyocytes,
especially because reprogrammed cardi-
omyocytes were similar but not identical
to neonatal cardiomyocytes.
There will be obvious important clinical
implications if generic and robust iCM
production protocols can be developed
and applied for adult human cells.
Althoughmany hurdles remain to be over-
come in order to establish effective cell-
based therapies (Passier et al., 2008),
patient-derived iCMs may be used in
the future for treatment of heart disease
and would offer advantages over iPSC-derived cardiomyocytes. First, direct re-
programming avoids residual pluripotent
stemcells in the transplanted populations,
eliminating the risk of teratoma formation.
Second, higher yields and faster kinetics
of cardiomyocyte production would lower
the costs and reduce the delivery time to
patients andmay permit the use of autolo-
gous cells even for acute conditions.
Nevertheless, other safety issues would
still need to be addressed, including the
risk of genomic integration of foreign
genetic material, spontaneous transfor-
mation during cell expansion in culture,
and cardiac arrhythmias after transplanta-
tion to the human heart. Besides future
therapeutic applications, however, much
more immediate clinical relevance is
found in the biotechnology and pharma-
ceutical industries. These companies are
actively seekingpredictive humandisease
models for target and drug discovery.
Future comparisons between human
pluripotent stem cell-derived (both from
iPSCs or genetically manipulated human
ESCs) or directly reprogrammed cardio-
myocytes (or other specialized cell types)
with native populations will be needed to
determine the relevance of any of theseCell Stem Cel‘‘manufactured’’ cells for high-throughput
drug and compound screening.
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Neural precursor cells (NPCs) reside in the subventricular zone in association with blood vessels and epen-
dymal cells. In this issue of Cell Stem Cell, Kokovay et al. (2010) show that SDF1 directs the association of
NPCs with this niche and regulates their lineage progression in a stage-specific manner.In the adult brain, a few areas of active
neurogenesis churn out new neurons
that will ultimately incorporate into the ex-
isting circuitry of specific brain structures.
One of these areas is the subventricular
zone (SVZ) lining the lateral ventricles,
where the progression from quiescent
stem cell to migrating neuroblast followsan orchestrated program (Figure 1). Qui-
escent multipotential neural stem cells
(NSCs), called B cells, are found in the
SVZ. When activated they produce rap-
idly dividing type C transient-amplifying
cells that then give rise to type A neuro-
blasts. The neuroblasts then migrate
away from the lateral ventricles to theolfactory bulbs via the rostral migratory
stream (Miller and Gauthier-Fisher, 2009).
In addition to understanding the lineage
relationship between neural cells in the
SVZ, there is increasing focus on how
the SVZ microenvironment both helps
maintain the stem cell pool and facilitates
neuroblast production. Understandingl 7, August 6, 2010 ª2010 Elsevier Inc. 141
